...
首页> 外文期刊>Clinical oncology >Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK
【24h】

Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK

机译:Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK

获取原文
获取原文并翻译 | 示例
           

著录项

  • 来源
    《Clinical oncology》 |2021年第1期|15-19|共5页
  • 作者单位

    Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Box 193 R4,Hills Rd, Cambridge CB2 0QQ, England;

    Univ Warwick, Warwick Clin Trials Unit, Coventry, W Midlands, England;

    Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, ScotlandUniv Birmingham, Inst Canc & Genom Sci, Canc Res UK Clin Trials Unit CRCTU, Birmingham, W MidlandsCambridge Univ Hosp NHS Fdn Trust, Cambridge, EnglandUniv Edinburgh, Inst Genet & Mol Med, Canc Res Ctr, Western Gen Hosp, Edinburgh, MidlothianGuys & St Thomas NHS Fdn Trust, Guys Hosp, Dept Med Oncol, London, EnglandRoyal Cornwall Hosp NHS Trust, Truro, EnglandIndependent Canc Patients Voice, London, EnglandMt Vernon Canc Ctr, Northwood, Middx, EnglandChristie, NIHR Manchester Clin Res Facil, Manchester, Lancs, England;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类 肿瘤学;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号